432 related articles for article (PubMed ID: 19154706)
1. [Risperidone use in child and adolescent psychiatric patients].
Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D
Therapie; 2008; 63(5):359-75. PubMed ID: 19154706
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of comorbidities of Tourette's syndrome and bipolar disorder in a 10-year-old boy.
Wang PW; Huang MF; Yen CF; Huang RR
Kaohsiung J Med Sci; 2009 Nov; 25(11):608-12. PubMed ID: 19858040
[TBL] [Abstract][Full Text] [Related]
3. Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.
Malone RP; Maislin G; Choudhury MS; Gifford C; Delaney MA
J Am Acad Child Adolesc Psychiatry; 2002 Feb; 41(2):140-7. PubMed ID: 11837403
[TBL] [Abstract][Full Text] [Related]
4. Use of antipsychotics in children and adolescents.
Findling RL; Steiner H; Weller EB
J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.
Troost PW; Lahuis BE; Steenhuis MP; Ketelaars CE; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1137-44. PubMed ID: 16239862
[TBL] [Abstract][Full Text] [Related]
6. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
[TBL] [Abstract][Full Text] [Related]
7. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
Weiden PJ; Cutler AJ; Polymeropoulos MH; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908
[TBL] [Abstract][Full Text] [Related]
8. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
McDougle CJ; Scahill L; McCracken JT; Aman MG; Tierney E; Arnold LE; Freeman BJ; Martin A; McGough JJ; Cronin P; Posey DJ; Riddle MA; Ritz L; Swiezy NB; Vitiello B; Volkmar FR; Votolato NA; Walson P
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):201-24. PubMed ID: 10674197
[TBL] [Abstract][Full Text] [Related]
9. Role of risperidone in children with autism spectrum disorder.
Chavez B; Chavez-Brown M; Rey JA
Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
Okugawa G; Kato M; Wakeno M; Koh J; Morikawa M; Matsumoto N; Shinosaki K; Yoneda H; Kishimoto T; Kinoshita T
Psychiatry Clin Neurosci; 2009 Jun; 63(3):322-8. PubMed ID: 19566763
[TBL] [Abstract][Full Text] [Related]
11. The safety and tolerability of atypical antipsychotics in bipolar disorder.
Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
[TBL] [Abstract][Full Text] [Related]
12. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
13. Risperidone in children with autism and serious behavioral problems.
Munarriz R; Bennett L; Goldstein I
N Engl J Med; 2002 Dec; 347(23):1890-1; author reply 1890-1. PubMed ID: 12472072
[No Abstract] [Full Text] [Related]
14. Addressing adverse effects of antipsychotic treatment in young patients with schizophrenia.
Correll CU
J Clin Psychiatry; 2011 Jan; 72(1):e01. PubMed ID: 21272508
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety of combination therapy with lithium and risperidone.
Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W
Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646
[No Abstract] [Full Text] [Related]
16. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
Keith S
Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665
[TBL] [Abstract][Full Text] [Related]
17. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.
Correll CU
J Clin Psychiatry; 2008; 69 Suppl 4():26-36. PubMed ID: 18533766
[TBL] [Abstract][Full Text] [Related]
18. Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series.
Saxena K; Chang K; Steiner H
Bipolar Disord; 2006 Aug; 8(4):405-10. PubMed ID: 16879141
[TBL] [Abstract][Full Text] [Related]
19. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic medications in children and adolescents.
Findling RL; Grcevich SJ; Lopez I; Schulz SC
J Clin Psychiatry; 1996; 57 Suppl 9():19-23. PubMed ID: 8823346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
